Outset Medical, Inc. Interest Expense
Outset Medical, Inc. (OM) reported Interest Expense of $3.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:InterestExpense · last filed 2026-08-06
- Outset Medical, Inc. interest expense for the quarter ending 2026-06-30 was $3.44M, a 0.95% decline year-over-year.
- Outset Medical, Inc. interest expense for the quarter ending 2026-03-31 was $3.37M, a 5.37% decline year-over-year.
- Outset Medical, Inc. interest expense for the quarter ending 2025-12-31 was $3.44M, a 40.93% decline year-over-year.
- Outset Medical, Inc. interest expense for the quarter ending 2025-09-30 was $3.48M, a 42.72% decline year-over-year.
- Outset Medical, Inc. interest expense for fiscal 2025 was $13.95M, a 41.55% decline from fiscal 2024.
- Outset Medical, Inc. interest expense for fiscal 2024 was $23.87M, a 88.33% increase from fiscal 2023.
- Outset Medical, Inc. interest expense for fiscal 2023 was $12.68M, a 255.44% increase from fiscal 2022.
- Outset Medical, Inc. interest expense for fiscal 2022 was $3.57M, a 107.93% increase from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.44M 10-Q · filed 2026-08-06 | $6.81M 10-Q · filed 2026-08-06 | $10.25M derived: sum of 3 quarters · filed 2026-08-06 | $13.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.37M 10-Q · filed 2026-05-07 | $6.81M derived: sum of 2 quarters · filed 2026-05-07 | $10.29M derived: sum of 3 quarters · filed 2026-05-07 | $13.76M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $6.92M derived: sum of 2 quarters · filed 2026-02-13 | $10.39M derived: sum of 3 quarters · filed 2026-08-06 | $13.95M 10-K · filed 2026-02-13 |
| 2025-09-30 | $3.48M 10-Q · filed 2025-11-10 | $6.95M derived: sum of 2 quarters · filed 2026-08-06 | $10.51M 10-Q · filed 2025-11-10 | $16.34M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.48M 10-Q · filed 2026-08-06 | $7.04M 10-Q · filed 2026-08-06 | $12.86M derived: sum of 3 quarters · filed 2026-08-06 | $18.93M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $3.56M 10-Q · filed 2026-05-07 | $9.38M derived: sum of 2 quarters · filed 2026-05-07 | $15.45M derived: sum of 3 quarters · filed 2026-05-07 | $21.46M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $11.89M derived: sum of 2 quarters · filed 2026-02-13 | $17.90M derived: sum of 3 quarters · filed 2026-02-13 | $23.87M 10-K · filed 2026-02-13 |
| 2024-09-30 | $6.07M 10-Q · filed 2025-11-10 | $12.08M derived: sum of 2 quarters · filed 2025-11-10 | $18.05M 10-Q · filed 2025-11-10 | $21.46M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $6.01M 10-Q · filed 2025-08-07 | $11.98M 10-Q · filed 2025-08-07 | $15.39M derived: sum of 3 quarters · filed 2026-02-13 | $18.61M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $5.97M 10-Q · filed 2025-05-08 | $9.38M derived: sum of 2 quarters · filed 2026-02-13 | $12.60M derived: sum of 3 quarters · filed 2026-02-13 | $15.70M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $6.63M derived: sum of 2 quarters · filed 2026-02-13 | $9.73M derived: sum of 3 quarters · filed 2026-02-13 | $12.68M 10-K · filed 2026-02-13 |
| 2023-09-30 | $3.21M 10-Q · filed 2024-11-07 | $6.32M derived: sum of 2 quarters · filed 2024-11-07 | $9.26M 10-Q · filed 2024-11-07 | $11.35M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $3.10M 10-Q · filed 2024-08-08 | $6.04M 10-Q · filed 2024-08-08 | $8.14M derived: sum of 3 quarters · filed 2025-02-28 | $8.71M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $2.94M 10-Q · filed 2024-05-09 | $5.04M derived: sum of 2 quarters · filed 2025-02-28 | $5.61M derived: sum of 3 quarters · filed 2025-02-28 | $6.09M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $2.66M derived: sum of 2 quarters · filed 2025-02-28 | $3.14M derived: sum of 3 quarters · filed 2025-02-28 | $3.57M 10-K · filed 2025-02-28 |
| 2022-09-30 | $567.00K 10-Q · filed 2023-11-08 | $1.05M derived: sum of 2 quarters · filed 2023-11-08 | $1.47M 10-Q · filed 2023-11-08 | $1.90M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $481.00K 10-Q · filed 2023-08-03 | $903.00K 10-Q · filed 2023-08-03 | $1.33M derived: sum of 3 quarters · filed 2024-02-21 | $1.76M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $422.00K 10-Q · filed 2023-05-04 | $853.00K derived: sum of 2 quarters · filed 2024-02-21 | $1.28M derived: sum of 3 quarters · filed 2024-02-21 | $1.72M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $862.00K derived: sum of 2 quarters · filed 2024-02-21 | $1.29M derived: sum of 3 quarters · filed 2024-02-21 | $1.72M 10-K · filed 2024-02-21 |
| 2021-09-30 | $431.00K 10-Q · filed 2022-11-09 | $862.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.28M 10-Q · filed 2022-11-09 | $1.71M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $431.00K 10-Q · filed 2022-08-02 | $853.00K 10-Q · filed 2022-08-02 | $1.28M derived: sum of 3 quarters · filed 2023-02-13 | $1.71M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $422.00K 10-Q · filed 2022-05-05 | $852.00K derived: sum of 2 quarters · filed 2023-02-13 | $1.28M derived: sum of 3 quarters · filed 2023-02-13 | $2.31M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $430.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $858.00K derived: sum of 2 quarters · filed 2023-02-13 | $1.89M derived: sum of 3 quarters · filed 2023-02-13 | $2.89M 10-K · filed 2023-02-13 |
| 2020-09-30 | $428.00K 10-Q · filed 2021-11-04 | $1.46M derived: sum of 2 quarters · filed 2021-11-04 | $2.46M 10-Q · filed 2021-11-04 | $3.48M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $1.03M 10-Q · filed 2021-08-06 | $2.03M 10-Q · filed 2021-08-06 | $3.05M derived: sum of 3 quarters · filed 2022-02-23 | $4.10M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $1.00M 10-Q · filed 2021-05-06 | $2.02M derived: sum of 2 quarters · filed 2022-02-23 | $3.07M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2019-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $2.07M derived: sum of 2 quarters · filed 2022-02-23 | $4.26M 10-K · filed 2022-02-23 | |
| 2019-09-30 | $1.05M 10-Q · filed 2020-11-12 | $3.24M 10-Q · filed 2020-11-12 | ||
| 2018-12-31 | $4.64M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |